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AP-1Clathrin-mediated endocytosis was previously implicated as one of the cellular pathways involved in ﬁloviral
glycoprotein mediated viral entry into target cells. Here we have further dissected the requirements for
different components of this pathway in Ebola versus Marburg virus glycoprotein (GP) mediated viral
infection. Although a number of these components were involved in both cases; Ebola GP-dependent viral
entry speciﬁcally required the cargo recognition proteins Eps15 and DAB2 as well as the clathrin adaptor
protein AP-2. In contrast, Marburg GP-mediated infection was independent of these three proteins and
instead required beta-arrestin 1 (ARRB1). These ﬁndings have revealed an unexpected difference between the
clathrin pathway requirements for Ebola GP versus Marburg GP pseudovirion infection. Anthrax toxin also
uses a clathrin-, and ARRB1-dependent pathway for cellular entry, indicating that the mechanism used by
Marburg GP pseudovirions may be more generally important for pathogen entry.d Molecular Biology, Feinberg
-140, 303 E. Chicago Avenue,
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The Filoviridae family comprises of Marburg virus (MARV) and
Ebola virus (EBOV), the causative agents of viral hemorrhagic fever
(Schnittler and Feldmann, 2003). There have been several sporadic
outbreaks of these virus infections since the late 1960's, the most
recent occurring in 2008 in Uganda (MARV), and in 2009 in the
Democratic Republic of the Congo (EBOV). The high fatality rates
associated with these viruses represents a potential global health
challenge and also makes them ideal candidates for use as biological
weapons. Consequently, these viruses have been classiﬁed as
Category A Bioterrorism Agents by the US Centers for Disease Control
and Prevention (CDC). There are currently no effective drugs or
licensed vaccines to protect humans against ﬁlovirus infection
(Sullivan et al., 2009). Therefore, there is an urgent need to betterunderstand the mechanisms that control ﬁlovirus replication for
designing effective therapeutic measures.
The target cells for ﬁloviral infection are monocytes, macrophages,
dendritic cells and endothelial cells (Connolly et al., 1999;Geisbert et
al., 2003). Several cell surface proteins have been implicated in
ﬁlovirus entry including folate receptor alpha (Chan et al., 2001),
lectins (Alvarez et al., 2002; Ji et al., 2005; Marzi et al., 2006; Simmons
et al., 2003a;Takada et al., 2004), beta 1 integrins (Takada et al., 2000)
and TAM receptors (Shimojima et al., 2006). T-cell immunoglobulin
and mucin domain 1 (TIM-1) was recently reported to be a receptor
for Ebola as well as Marburg virus (Kondratowicz et al., 2011),
suggesting that these viruses bind to a common receptor.
Filovirus entry is mediated by the virus-encoded glycoprotein
(GP), located on the viral surface lipid bilayer. The ﬁloviral GP is a
homotrimeric, class I viral fusion protein, expressed as a precursor
that is post-translationally cleaved in the Trans Golgi Network (TGN)
by a cellular proprotein convertase furin into the disulﬁde-linked GP1
(140 kD) and GP2 (26 kD) subunits (Jeffers et al., 2002;Volchkov et al.,
1998). GP1 is primarily involved in receptor binding whereas GP2
facilitates virus–cell membrane fusion (White et al., 2008).
Following cell surface receptor binding, ﬁloviruses are taken up by
endocytosis. Using multiple approaches and cell lines we have
previously shown that Ebola GP pseudovirus uses clathrin-mediated
endocytosis as an entry pathway (Bhattacharyya et al., 2010). We also
found that treatment with chlorpromazine, which was previously
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inhibited wild type (WT) Ebola. However, it is now known that
chlorpromazine also inhibits macropinocytosis and hence is not a
speciﬁc inhibitor of the clathrin pathway (Ivanov, 2008). Clathrin and
macropinocytic pathways have also been implicated in ﬁlovirus
infection by other groups (Quinn et al., 2009;Sanchez, 2007); while
the role of caveolae pathway has been both implicated and refuted
(Empig and Goldsmith, 2002;Simmons et al., 2003b). It was recently
suggested that while ﬁloviral glycoprotein pseudotyped viruses enter
via the clathrin pathway (Hunt et al., 2010); wild type ﬁloviruses
predominantly use macropinocytosis for entry (Nanbo et al., 2010;
Saeed et al., 2010). These differences in entry pathway requirements
could be due to the differences in size and shape of pseudovirions
versus WT viruses (Cureton et al., 2010).
Upon entry, ﬁloviruses are trafﬁcked by cellular endocytic
machinery to an acidic endosomal compartment, which is the site of
virus–cell membrane fusion. The Ebola virus GP is activated to trigger
fusion through proteolytic cleavage mediated by cellular lysosomal
cysteine proteases, cathepsins B and L (Chandran et al., 2005; Kaletsky
et al., 2007; Sanchez, 2007;Schornberg et al., 2006).
In this report we have investigated the speciﬁc requirements for
different components of the clathrin endocytic machinery in Ebola GP
versus Marburg GP pseudovirion entry. These studies have demon-
strated that these two highly related glycoproteins exhibit differential
requirements for several players of this pathway, uncovering critical
differences in their entry mechanisms. Moreover, the factors required
for Marburg GP mediated entry are very similar to those previously
described for anthrax toxin entry (Abrami et al., 2010), suggesting
that these components of the clathrin pathway may be broadly
required by various pathogens to enter target cells.Results
To examine virus entry mediated by MARVGP and EbGP, we
exploited a previously used envelope protein-deﬁcient lentiviral
(HIV-1) vector system (Bhattacharyya et al., 2010) pseudotyped
with the Ebola or Marburg GP. As expected, infection of HOS cells by
both types of ﬁlovirus GP pseudovirions was dependent upon low
endosomal pH as well as cathepsin (Cat) L cleavage since it was
blocked by treatment with the vacuolar ATPase inhibitor Baﬁlomycin
A1 and the Cat L inhibitor FYdmk, respectively (Supplemental Fig. 1).
For control purposes, we showed that these treatments did not impair
infection with an isogenic HIV vector carrying the wild-type envelope
protein, which directs pH-independent cellular entry (Miyauchi et al.,
2009;Stein et al., 1987) or HIV pseudotyped with VSVg, which
mediates low-pH dependent but Cat L independent entry (Chandran
et al., 2005) (Supplemental Fig. 1).
Previously, we showed that EbGP-dependent virus infection was
blocked by treatment with two chemical inhibitors of the clathrin
endocytic pathway; chlorpromazine and sucrose, and by RNAi-
mediated knockdown of the clathrin heavy chain (CHC) (Bhattacharyya
et al., 2010). To assess the role of clathrin-mediated endocytosis in
MARVGP pseudovirion entry, we evaluated the effects of these
treatments on infection. Similar to EbGP-mediated virus infection,
MARVGP-mediated infection of HOS cells was blocked by treatment
with either 10 μg/ml chlorpromazine (Fig. 1A) or 0.45 M sucrose
(Fig. 1B), or by treatmentwith both inhibitors (Fig. 1C). These inhibitors
also blocked MARVGP-dependent infection in physiologically relevant
human microvascular endothelial cells (HMEC) (Fig. 1D). MARVGP-
mediated infection was also blocked speciﬁcally by two independent
siRNAs, which signiﬁcantly knocked down the levels of CHC mRNA
without causing any overt cytotoxicity (Figs. 1E–G). As expected, none
of these treatments inhibited infection by the control HIV-1 virus. Taken
together, these results demonstrate that MARVGP pseudovirions utilize
a clathrin-dependent pathway for cellular entry.Eps15 and AP-2 are speciﬁcally required for EbGP mediated entry
The cellular protein Eps15 links ubiquitinated cargo to clathrin
through its binding to the alpha-subunit of AP-2 (Traub, 2003).
Previously, we showed that expression of a dominant-negative
version of Eps15 (DIII) blocks infection by EbGP-pseudotyped virus
(Bhattacharyya et al., 2010). We tested the effect of this molecular
inhibitor on MARVGP pseudotyped virus and surprisingly, it had no
impact on infection (Fig. 2). Since Eps15 is known to constitutively
associate with AP-2 (Benmerah et al., 1995), we then examined the
effect of RNAi-mediated knockdown of AP-2 on both EbGP and
MARVGP-dependent entry. As anticipated, EbGP-dependent infection
was blocked by two siRNAs that knocked down the mRNA expression
levels of AP-2 without altering cell viability, whereas MARVGP-
mediated infection was not blocked by these siRNAs (Figs. 3A–C). We
conclude that the mechanism of EbGP-mediated infection is depen-
dent on both Eps15 and AP-2 whereas MARVGP-mediated infection is
independent of these two cellular factors.Differential requirements for ARRB1 and DAB2 in Marburg GP versus
Ebola GP mediated entry
To further investigate the clathrin pathway requirements for
EbGP and MARVGP-dependent entry, we tested the roles played by
several members of this pathway including epsin 1, intersectin 1
(ITSN1), dynamin 2 (DYN2), adaptor-related protein complex 1, mu
1 subunit (AP1M1), disabled homolog 2 (DAB2), low density
lipoprotein receptor adaptor protein 1 (LDLRAP1), inositol polypho-
sphate phosphatase-like 1 (INPPL1), phosphatidylinositol binding
clathrin assembly protein (PICALM), beta-arrestin 1 (ARRB1),
huntingtin interacting protein 1 (HIP1), Drosophila numb homolog
(NUMB), RALBP1 associated Eps domain containing 1 (REPS1) and
RALBP1 associated Eps domain containing 2 (REPS2). The roles of
these factors in the clathrin pathway are described in the Discussion
section.
Two independent siRNAs were employed that signiﬁcantly
knocked down mRNA expression levels of each of these factors
without adversely impacting cell viability (Supplemental Fig. 3). Some
of these siRNAswere extensively validated in a previous study (Huang
et al., 2004), while the remaining siRNAs were chosen from a well-
characterized Dharmacon library. For practical purposes, the genes
were tested in 3 groups: group 1 genes are shown in black bars, group
2 in dark gray bars and group 3 in light gray bars (Fig. 4).
These studies revealed that epsin 1, ITSN1, LDLRAP1, INPPL1,
PICALM, NUMB, REPS1 and REPS2 were required by both MARVGP
and EbGP suggesting a conserved requirement for these factors in
ﬁloviral GP mediated entry. The siRNAs targeting these factors had
no impact on infection by the isogenic vector containing the HIV-1
envelope protein, indicating that they do not inﬂuence a post-entry
step of infection (Fig. 4). By contrast, DYN2 and AP-1 also inhibited
infection by HIV-1, suggesting that these proteins may be required
for the endocytosis-dependent infection of the viruses. DYN2 could
possibly mediate HIV-1 entry via macropinocytosis (Liu et al., 2008;
Marechal et al., 2001) and endosomal fusion of HIV-1 particles
(Miyauchi et al., 2009). AP-2 and beta-arrestins are known to
mediate endocytosis of G protein-coupled receptors (GPCRs)
(Shimizu et al., 2009) and HIV-1 co-receptors CXCR4 and CCR5 are
GPCRs (Unutmaz et al., 1998), which could explain the inhibitory
effects of the AP-2 and ARRB1 siRNAs on HIV-1 infection. siRNA-
mediated knockdown of HIP-1 also reduced infection by all three of
these viruses, although statistically signiﬁcant levels of inhibition
with both siRNAs were obtained only with the EbGP pseudotyped
virus (Fig. 4). Most importantly, these studies demonstrated that
EbGP and MARVGP speciﬁcally employ DAB2 and ARRB1, respec-
tively for entry (Fig. 4).
Fig. 1. Chlorpromazine (CPZ), sucrose and RNAi-knockdown of clathrin heavy chain (CHC) inhibit Marburg GP mediated viral entry. (A) HOS cells were pre-treated with 10 μg/ml
chlorpromazine for 45 min followed by incubation with a Marburg GP (MARVGP) or Ebola GP (EbGP) pseudotyped HIV-1 vector encoding GFP or wild type (WT) HIV overnight in
the presence of the drug. 48 h post-infection, viral infectivity was measured by ﬂow cytometry. Error bars represent SEM for three independent samples. * p value for MARVGPb0.05
and EbGPb0.001. (B) HOS cells were pre-treated with 0.45 M sucrose for 10 min followed by incubation with the viruses described in panel (A) overnight in the presence of the drug.
48 h post-infection, viral infectivity was measured by ﬂow cytometry. Error bars represent SEM for three independent samples. * p values for MARVGP and EbGPb0.05. (C) HOS cells
were pre-treated with a combination of 10 μg/ml chlorpromazine and 0.45 M sucrose for 45 min followed by incubation with the viruses described in panel A overnight in the
presence of the drugs. 48 h post-infection, viral infectivity was measured by ﬂow cytometry. Error bars represent SEM for three independent samples. * p values for MARVGP, EbGP
and HIVb0.01. (D) HMEC cells were pre-treated with 10 μg/ml chlorpromazine for 45 min or 0.45 M sucrose for 10 min followed by incubation with the MARVGP pseudotyped virus
overnight in the presence of the drug. Viral infectivity was measured at 48 h post-infection by ﬂow cytometry. Error bars represent SEM for three independent samples. * p values for
CPZ and sucroseb0.001. (E) HOS cells were co-transfected with two siRNAs against CHC and a tdTomato plasmid (as a transfection marker) followed by infection with the viruses as
described in panel (A). The data is represented as % infectivity in speciﬁc siRNA-transfected cells normalized to non-targeting siRNA transfected cells. Individual bars represent single
siRNAs. Error bars represent SEM for three independent experiments. * p values for MARVGP siRNAsb0.01 and for EbGP: siRNA 1b0.01, siRNA 2b0.05. (F) HOS cells were transfected
with two siRNAs against CHC as described in the Materials and methods section. mRNA expression levels were measured by qPCR and normalized to cellular beta-actin mRNA
expression levels. Individual bars represent single siRNAs. Error bars represent SEM for three independent experiments. * p values for siRNA 1b0.01 and siRNA 2b0.05. (G) HOS cells
were transfected with two siRNAs against CHC as described in the Materials and methods section and cell viability was measured using the Cell Titer Glo reagent (Promega). Data
from one representative experiment is shown in the ﬁgure. Individual bars represent single siRNAs. Error bars represent standard deviation for eight replicates.
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We previously used S15-mCherry and GFP-Vpr double-labeled,
VSVg pseudotyped HIV to monitor virus fusion by deconvolutionmicroscopy; S15-mCherry is very efﬁciently incorporated into the viral
lipid membrane and the loss of mCherry signal during infection
corresponds to viral fusion events (Campbell et al., 2007). Therefore,
we generated a similar double-labeled MARVGP pseudotyped HIV to
Fig. 2.Dominant-negative Eps15 does not inhibit Marburg GPmediated viral entry. HOS
cells were plated on coverslips and transfected with mRFP-DIII (dominant-negative,
DN) or D3Δ2 (control) Eps15 plasmids. 24 h post-transfection, EbGP, MARVGP
pseudotyped viruses or WT-HIV was added to the cells for 4 h. 48 h post-infection,
the cells were ﬁxed and the DNA was stained with Hoechst. Several panels of images
were collected from each coverslip. The number of transfected only and transfected and
infected cells was counted in each panel and the percentage of transfected and infected
cells was determined. Graph represents % decline in viral infectivity in DN Eps15
transfected cells normalized to control Eps15 transfected cells. Error bars represent
SEM for three independent experiments. * p value for % decline in EbGP infectivity
compared to MARVGP and HIV is b0.01.
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Previous studies demonstrated that the halftime of MARVGP pseudo-
typedHIVentry and fusion varies from~50 min inHeLacells (Yonezawa
et al., 2005) to ~3 to 4 h in HEK293T cells (Empig and Goldsmith, 2002).
Therefore, wemonitoredMARVGP pseudotyped HIV entry at 1, 2, 3 and
4 h post-infection in HOS cells co-transfected with ARRB1 siRNAs and
pTagBFP (as a transfection marker), which encodes a blue ﬂuorescent
protein. Several panels of images were collected for each sample at
every time point and the total numbers of S15-mCherry and GFP-Vpr
double-positive virus particles as well as the GFP-Vpr single-positive
virus particles in the BFP positive cells were counted. The raw data is
shown in Supplemental Table 1. These studies demonstrated that virus
fusion is signiﬁcantly delayed in cells where ARRB1 is knocked down
wherein compared to control siRNA transfected cells, no virus fusionFig. 3. Ebola GP requires AP-2 for entry but Marburg GP does not. (A) HOS cells were co-trans
followed by infection with the viruses as described in the Materials and methods section. T
non-targeting siRNA transfected cells. Individual bars represent single siRNAs. Error bars rep
siRNA 1b0.05. (B) HOS cells were transfected with two siRNAs against AP-2 as described in t
and normalized to cellular beta-actin mRNA expression levels. Individual bars represent sin
siRNA 1b0.01 and siRNA 2b0.05. (C) HOS cells were transfected with two siRNAs against A
using the Cell Titer Glo reagent (Promega). Data from one representative experiment is sho
deviation for eight replicates.wasobserved at 1–2 hpost-infection and therewere fewer fused virions
at 3–4 h post-infection (Figs. 5A and B). These results show that there is
no obvious defect in virus binding to cells deﬁcient in ARRB1but instead
the block lies at a post-binding step leading to virus fusion.
Discussion
In this report we have shown that like Ebola GP pseudovirions,
Marburg GP pseudovirion entry also involves clathrin-mediated
endocytosis. Furthermore, a number of components of the clathrin
endocytic pathway are generally required by both Ebola and Marburg
GP pseudovirions. However, whereas Ebola GP pseudovirions speciﬁ-
cally require Eps15, AP-2, and DAB2, Marburg GP pseudovirions
speciﬁcally require ARRB1 (Fig. 6A).
These differential requirements point to unexpected differences
between the entry mechanisms used by EbGP and MARVGP pseudo-
virions. Eps15 and DAB2 are involved in cargo recognition, interacting
with different labels on cell surface proteins that are destined for
internalization by the clathrin pathway. The EH domains of Eps15
interact with NPF motifs and recognize ubiquitin residues on its cargo
(Salcini et al., 1997;Traub, 2003), whereas DAB2 recognizes an NPXY
internalization sequence through its PTB domain (Mishra et al., 2002).
Both of these factors bind to theα-adaptin subunit of AP-2 (Fig. 6B), an
interaction that appears to be critically important for EbGP-mediated
virus entry. By contrast, ARRB1, which is selectively important for
MARVGP-mediated infection, recognizes phosphorylated serine and
threonine residues onGPCRs (Oakley et al., 2001) andbinds both to the
beta-adaptin subunit of AP-2 as well as directly to clathrin through its
C-terminus (Traub, 2003;Traub, 2009). Also, blocking interaction of
ARRB1 with AP-2 was shown to enhance its interaction with clathrin
(Schmid et al., 2006). Therefore, since AP-2 is not required for
MARVGP-mediated virus entry, our results suggest that perhaps the
direct interaction between ARRB1 and clathrin is important in this
case. Furthermore, our results also demonstrate that ARRB1 is involved
in post-binding and pre-fusion step(s) of MARVGP pseudotyped virus
trafﬁcking.
In addition to Eps15, other proteins involved in clathrin-mediated
endocytosis such as Epsin 1, ITSN1, REPS1 and REPS2 are known to
possess Eps homology (EH) domains (Hussain et al., 1999; Naslavsky
and Caplan, 2005;Polo et al., 2003). Epsin 1 is involved in clathrin-
mediated endocytosis of inﬂuenza virus (Chen and Zhuang, 2008),fected with two siRNAs against AP-2 and a tdTomato plasmid (as a transfection marker)
he data is represented as % infectivity in speciﬁc siRNA-transfected cells compared to
resent SEM for three independent experiments. * p values for EbGP siRNAs and for HIV
he Materials and methods section. The mRNA expression levels were measured by qPCR
gle siRNAs. Error bars represent SEM for three independent experiments. * p value for
P-2 as described in the Materials and methods section and cell viability was measured
wn in the ﬁgure. Individual bars represent single siRNAs. Error bars represent standard
Fig. 4. Ebola and Marburg GP mediated entry have differential requirements for DAB2 and ARRB1. (A) HOS cells were co-transfected with two siRNAs each against epsin 1, ITSN1,
DYN2, AP1M1, DAB2, LDLRAP1, INPPL1, PICALM, ARRB1, HIP1, NUMB, REPS1 and REPS2 and a tdTomato plasmid (as a transfection marker) followed by infection with the MARVGP
pseudotyped virus as described in the Materials and methods section. The data is represented as % infectivity in speciﬁc siRNA-transfected cells normalized to non-targeting siRNA
transfected cells. Individual bars represent single siRNAs for each gene. Error bars represent SEM for three independent experiments. * p values for epsin1, AP1M1 and REPS1
siRNAsb0.01; ITSN1: siRNA 1b0.01, siRNA 2b0.05; DYN2 and REPS2 siRNAsb0.05; LDLRAP1: siRNA 1b0.05, siRNA 2b0.01; INPPL1 siRNAsb0.001; PICALM: siRNA 1b0.01, siRNA
2b0.05; ARRB1: siRNA 1b0.01, siRNA 2b0.001 and NUMB: siRNA 1b0.05, siRNA 2b0.01. (B) HOS cells were co-transfected with the siRNAs described in panel (A) and a tdTomato
plasmid followed by infectionwith the EbGPpseudotyped virus as described in theMaterials andmethods section. The data is represented as % infectivity in speciﬁc siRNA-transfected
cells normalized to non-targeting siRNA transfected cells. Individual bars represent single siRNAs for each gene. Error bars represent SEM for three independent experiments.
* p values for epsin1, DAB2, LDLRAP1, INPPL1, PICALM and NUMB siRNAsb0.05; ITSN1 and DYN2 siRNAsb0.01; AP1M1 siRNA 1b0.001; HIP1: siRNA 1b0.05, siRNA 2b0.01; REPS1:
siRNA 1b0.05, siRNA 2b0.01 and REPS2: siRNA 1b0.05, siRNA 2b0.01. (C) HOS cells were co-transfected with the siRNAs described in panel (A) and a tdTomato plasmid followed by
infectionwithWT-HIV as described in theMaterials andmethods section. The data is represented as % infectivity in speciﬁc siRNA-transfected cells normalized to non-targeting siRNA
transfected cells. Individual bars represent single siRNAs for each gene. Error bars represent SEM for three independent experiments. * p values for DYN2: siRNA1b0.01, siRNA 2b0.05;
AP1M1 siRNAsb0.01; PICALM: siRNA 2b0.05; ARRB1: siRNA 1b0.001, siRNA 2b0.05 and HIP1: siRNA 2b0.01.
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2006). Also, epsin 1 binds to both ITSN1 (Yamabhai et al., 1998) and
Eps15 (Chen et al., 1998) through the same EH-domain binding
sequence and therefore, simultaneous binding of Eps15 and ITSN1 is
unlikely. The Src homology 3 (SH3) domains of ITSN bind to dynamin
and synaptojanin (Sengar et al., 1999). Dynamin assembles at the neckof the coated pits and functions as a constrictase to pinch off the pits
(McNiven et al., 2000). DAB2 is known to function independently of
AP-2 and LDLRAP1 in sorting LDL receptor (Maurer and Cooper, 2006).
LDLRAP1 binds to clathrin and AP-2 (He et al., 2002). INPPL1 recruits
ITSN1 to clathrin-coated pits on the plasma membrane (Xie et al.,
2008). PICALM promotes assembly of clathrin triskelia into cages
Fig. 5. ARRB1 is required for efﬁcient MARVGP pseudovirion fusion. (A) HOS cells were
co-transfected with siRNAs against ARRB1 or negative control (NC) and TagBFP plasmid
(as a transfectionmarker) and challengedwith S15-mCherry and GFP-Vpr double-labeled
MARVGPpseudotypedvirus. At various timepoints, the cellswereﬁxedand several panels
of imageswere collected for each sample. The total numbers of S15-mCherry and GFP-Vpr
double-positive virus particles (yellow) as well as GFP-Vpr single-positive virus particles
(green) were counted in the BFP positive (blue) cells. Representative images from each
time point are shown. The white arrows indicate S15-mCherry and GFP-Vpr double-
positive virus particles (unfused virus) and the red arrows point towards GFP-Vpr single-
positive virus particles (fused virus). Scale bars represent 10 μm. (B) The total numbers of
S15-mCherry and GFP-Vpr double-positive virions as well as GFP-Vpr single-positive
virions in BFP positive cells were counted in the various panels of images collected from
each sample above. The loss of S15-mCherry signal corresponding to fused virions was
calculated for every sample for all the time points. Graph represents percentage of fused
virions for each sample at various time points. The initial viral input level was normalized
to 100%.
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(Goodman et al., 1996) and interaction of ARRB1 and 2 with AP-2 is
required for endocytosis of GPCRs (Hamdanet al., 2007). HIP1 localizes
with clathrin at the plasma membrane, is involved in the formation of
the coated vesicle (Gottfried et al., 2009;Legendre-Guillemin et al.,
2005) and can bind to AP-2 (Metzler et al., 2001). NUMB can bind to
the α-adaptin subunit of AP-2 (Santolini et al., 2000), Eps15 (Iannolo
et al., 1997) and EHD4 (Smith et al., 2004). REPS1 can form complexes
with two adaptor proteins Crk and Grb2 of the clathrin pathway
(Yamaguchi et al., 1997). REPS2 binds directly to epsin through its EHdomain (Morinaka et al., 1999). Thus, all these factors play important
roles in the clathrin endocytic pathway.
TIM-1 was recently shown to be a common receptor for ﬁloviruses
(Kondratowicz et al., 2011); therefore future studies characterizing the
interactions of TIM-1 with these factors of the clathrin endocytic
machinerywould provide further insights into the roles played by these
factors in EbGP and MARVGP-dependent viral entry. It would also be
interesting to investigate if there are any differential requirements for
host cell factors in ﬁloviral entry through macropinocytosis.
Some other viruses that, like MARVGP pseudovirions have Eps15
and AP-2 independent entry mechanisms include inﬂuenza virus and
mouse hepatitis virus type 2 (Lakadamyali et al., 2006;Pu and Zhang,
2008). A key ﬁnding from our study is that the clathrin pathway
requirements for MARVGP-mediated entry are strikingly similar to
those recently reported for anthrax toxin entry (Abrami et al., 2010).
In each case, cellular entry requires ARRB1, AP-1 and DYN2 but is
independent of Eps15 and AP-2. AP-1 has also been shown to play a
role in AP-2 independent, clathrin-mediated endocytosis of Listeria
monocytogenes (Cossart and Veiga, 2008). These ﬁndings raise the
intriguing possibility that a clathrin endocytic pathway, which is
deﬁned by ARRB1, AP-1 and DYN2 dependence is more generally
important for pathogen and/or microbial virulence factor entry into
cells. Studies are ongoing to further characterize this ARRB1 and AP-1
dependent pathway of virus entry.
Materials and methods
Cell lines, plasmids and chemicals
HEK293T cells, Human Osteo Sarcoma (HOS-CD4) cells and
Human Microvascular Endothelial Cells (HMEC) were maintained as
previously described (Bhattacharyya et al., 2010).
The plasmids pCB6-EbGP, VSVg, R7ΔEnvGFP, R73X4EnvGFP,
mRFP-dominant-negative (DN) Eps15 (DIII), control Eps15 (D3Δ2),
S15-mCherry and GFP-Vpr are previously described (Bhattacharyya et
al., 2010;Campbell et al., 2007). The plasmid encoding Marburg GP,
Musoke strain (pWRG7077) was received from Dr. M. Javad Aman
(Bavari et al., 2002). The TagBFP and tdTomato plasmids were
obtained from Dr. Michael W. Davidson and the latter plasmid was
made in Dr. Roger Tsien's lab (Shaner et al., 2004).
Polyethylenimine (PEI), Linear,MW25,000 (Polysciences, Inc.) and
chlorpromazine hydrochloride (Sigma) were dissolved in distilled
water tomake 1 mg/ml stock solutions. Sucrose (Fisher)was dissolved
in distilledwater tomake a 5 Mstock solution. Baﬁlomycin A1 (Baf A1)
(Sigma) and FYdmk (Calbiochem) were dissolved in DMSO to make
20 μM and 10 mM stock solutions respectively.
Pseudotyped virus production
For preparing Marburg GP pseudotyped virus, HEK293T cells in a
15-cm plate were transiently co-transfected with 20 μg of pWRG7077
encoding Marburg GP and 30 μg of R7ΔEnvGFP HIV plasmids using
112 μl of PEI. 48 h post-transfection, the supernatant was centrifuged
to pellet the cell debris and clariﬁed by ﬁltration through a 0.45 μm
pore-size ﬁlter. EbGP and VSVg pseudotyped viruses and
R73X4EnvGFP (wild type HIV) were prepared as previously described
(Bhattacharyya et al., 2010). Virus titer was measured using a p24
ELISA kit (Perkin Elmer Lifesciences). The S15-mCherry and GFP-Vpr
double-labeled virus was prepared as previously described (Campbell
et al., 2007).
Flow cytometric analysis to measure viral transduction following drug
treatments
HOS or HMEC cells in 12-well plates were pretreated with either
50 nM Baf A1 for 30 min or 0.45 M sucrose for 10 min or 10 μg/ml
Fig. 6. Schematic representation of the differential requirements for various components of the clathrin pathway in Ebola GP versus Marburg GP pseudotyped viral entry. (A) Ebola
GP requires Eps15, AP-2, DAB2 and possibly HIP1 for its entry. In contrast, Marburg GP mediated entry is independent of these factors but instead requires ARRB1 and AP-1. Both
viruses require CHC, epsin 1, ITSN1, DYN2, LDLRAP1, INPPL1, PICALM, NUMB, REPS1 and REPS2. The interactions of the factors with each other and also their roles in the formation of
clathrin vesicles are depicted. (B) Eps15, DAB2 and HIP1, which are required by EbGP mediated virus entry are known to bind to the alpha-appendage of AP-2. In contrast ARRB1,
which is required by MARVGP mediated virus entry is known to bind to the beta-appendage of AP-2. The target sequences recognized by these proteins are shown in parentheses.
Figure adapted from (Traub, 2003;Traub, 2009).
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zine and 0.45 M sucrose for 45 min for the various experiments. For the
cathepsin L inhibitor experiment, HOS cells were pre-incubated with
10 μM cathepsin L inhibitor (FYdmk) for 4.5 h. The working concentra-
tionof FYdmkwasprepared inDMEMcontaining1%DMSO. Ineachcase,
the cells were incubated with MARVGP, EbGP pseudotyped virus and
wild type HIV overnight in the presence of drug. For the cathepsin L
experiment, VSVg pseudotyped viruswas used as a negative control and
the viruses were added overnight in DMEM containing 1% DMSO in the
control cells. GFP ﬂuorescence as a marker of infectivity was measured
at 48 h post-infection by ﬂow cytometry using FACS Calibur (Becton
Dickinson). The cellsweregatedon forwardand side scatter and identical
gates were maintained for treated and control samples. Three indepen-
dent infection samples were analyzed for each virus and the % GFP
positive cells in the treated samplesnormalized tountreated sampleswas
calculated.
Immunoﬂuorescence analysis of viral transduction following transfection
with DN and control mRFP-Eps15 plasmids
HOS cells were plated on coverslips and transiently transfected
with DN or control mRFP-Eps15 plasmids using the Effectene
transfection reagent (Qiagen). 24 h post-transfection, the cells were
incubated with the various viruses for 4 h. 48 h post-infection, the
cells were ﬁxed and the DNAwas stainedwith Hoechst. The coverslipswere mounted onto glass slides with Gel Mount (Biomeda) and the
dried slides were imaged as previously described (Bhattacharyya et
al., 2010). The experiment was repeated three times and the % decline
in infectivity in DN Eps15 transfected cells normalized to control
Eps15 transfected cells was calculated using the following formula:
(number of transfected and infected cells; yellow)/(number of
transfected cells; red)×100%. The experimental scheme is shown in
Supplemental Fig. 2.
Immunoﬂuorescence study to examine viral transduction following
siRNA-mediated knockdown of clathrin endocytic pathway components
The siRNA duplexes (Dharmacon) were synthesized and used as
previously described (Huang et al., 2004). Two siRNAs against each
gene were included to rule out any potential off-target effects caused
by a single siRNA. The siRNA duplexes were diluted to 20 μM before
transfection. The target sequences and catalog numbers for the siRNAs
are described in Supplemental Table 2.
HOS cells were plated on coverslips in 12-well plates and incubated
inDMEMcontaining10% FBSwithout antibiotics for 24 h. The cellswere
transfected twice at 24 h intervals with 4 μl of each siRNA, 0.25 μg
tdTomato plasmid (as a transfection marker) and 3 μl of Lipofectamine
2000 reagent (Invitrogen) in OPTI-MEM I medium. Control cells were
similarly transfected with the non-targeting siRNA. The cells were
incubated with the viruses for 4 h at 24 h after the second transfection
8 S. Bhattacharyya et al. / Virology 419 (2011) 1–9for PICALM; at 48 h after the second transfection for CHC, epsin 1, ITSN1,
DYN2, DAB2, LDLRAP1, INPPL1, ARRB1, HIP1, NUMB, REPS1 and REPS2
and at 72 h after the second transfection for AP2B and AP1M1. The cells
wereﬁxedat48 hpost-infection and theDNAwas stainedwithHoechst.
The coverslips were mounted on glass slides and imaged with a Zeiss
Axioskop 2 microscope. Several panels of images were collected from
each coverslip and the number of transfected only aswell as transfected
and infected cells in each sample was counted. A minimum of 100
transfected cells was counted for each sample. The experiment was
repeated three times and % decline in viral infectivity in speciﬁc siRNA
treated cells normalized to non-targeting siRNA treated cells was
calculated.Quantitative PCR (qPCR) to measure mRNA expression levels following
siRNA-mediated knockdown of clathrin endocytic pathway components
The siRNA-mediated knockdowns were performed as described in
the previous section. RNA was isolated from the cells with the RNeasy
mini kit (Qiagen) and cDNAwas preparedwith the QuantiTect reverse
transcription kit (Qiagen). The qPCR reactions were normalized to
cellular beta-actin mRNA expression levels and performed on an ABI
Prism 7900HT Sequence Detection System using Power SYBRGreen
PCR master mix (Applied Biosystems). The experiment was repeated
three times and a dissociation curve analysis was performed for each
reaction with the SDS software (Applied Biosystems). The results
represent % mRNA expression levels in speciﬁc siRNA treated cells
normalized to non-targeting siRNA treated cells. The primer
sequences are described in Supplemental Table 3.Cell viability following siRNA-mediated knockdown of clathrin endocytic
pathway components
The siRNA-mediated knockdowns were performed as described in
the previous section and cell viability was measured using Cell Titer
Glo reagent (Promega) as per the manufacturer's guidelines.Immunoﬂuorescence analysis to examine MARVGP pseudotyped virus
fusion following siRNA-mediated knockdown of ARRB1
HOS cells on coverslips were co-transfected with the two ARRB1
siRNAs as described in the previous section using pTagBFP as a
transfection marker and at 48 h after the second transfection; the cells
were spinoculated with the S15-mCherry and GFP-Vpr double-labeled
MARVGP pseudotyped virus for 1.5 h at 17 °C. The cells were incubated
at 37 °C for 1 h, 2 h, 3 h or 4 h and then ﬁxed. The coverslips were
mounted on glass slides and imaged using a Zeiss LSM 710 laser
scanning confocal microscope. Several panels of images were collected
from each coverslip and the total numbers of double-positive virus
particles aswell as GFP-Vpr single-positive virus particles were counted
in the ARRB1 siRNA-transfected versus control siRNA-transfected, BFP
positive cells.Statistical analysis of experimental data
p values were determined by comparing the treated versus control
samples using a paired student t test with the GraphPad InStat3
software. For the Eps15 experiment, the p value was determined by
comparing the % decline in infectivity of EbGP with respect to
MARVGP and HIV in cells transfected with DN Eps15 normalized to
control Eps15 using the one-way analysis of variance (ANOVA) test.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.virol.2011.07.018.Acknowledgments
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